Status:
COMPLETED
Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
Lead Sponsor:
Jubilee Mission Medical College and Research Institute
Conditions:
Upper Gastrointestinal Bleeding
Eligibility:
All Genders
18-100 years
Brief Summary
The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department se...
Detailed Description
UGIB is a ticking time-bomb and emergency physicians are challenged to accurately assess risk, and aggressively manage patients with gastrointestinal bleeding within the stipulated time in the confine...
Eligibility Criteria
Inclusion
- All patients presenting to ED with UGIB
- Age more than 18 years of age
Exclusion
- Patients not consenting to study
- Patients with known hematological disorders
- Patients in which endoscopy or blood transfusion is done outside
- Patients in which RDW value and laboratory parameters required for AIMS65 score are not available.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT04825977
Start Date
August 1 2018
End Date
October 31 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jubilee Mission Medical College and Research Institute
Thrissur, Kerala, India, 680027